Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this investigation is to determine the effects of Rituxan therapy in
individuals with rheumatoid arthritis on endothelial function and other markers of
endothelial function